Beth C. Seidenberg, Director, 10% Owner at Epizyme, Inc. (EPZM), sold 388,584 shares at $27.64 ($10.7M) on 2014-02-10, disclosed to the SEC on 2014-02-12.
Open-market sale of $10.7M EPZM by Director, 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VERA | SELL | 2024-09-20 | $1.3M | — | Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |